Phosphatidylinositol 3-kinase inhibitors (PI3Ki) are a class of drugs used to treat a specific type of breast cancer, known as hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated advanced breast cancer. However, some PI3Kis have been given US Food and Drug Administration (FDA) accelerated approval for the treatment of relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL). ...
Lymphoma
Explore the newest discoveries and latest clinical insights on lymphoma. Cancer Nursing Today provides the most current perspectives and data on predictive models for the prognosis of patients with diffuse large B-cell lymphoma, toxicities in triplet therapies, CAR T-cell therapies, and more. Explore the latest clinical trial data, conference coverage, and breaking news on lymphoma.
Advertisement
A case series demonstrated the effectiveness of a novel trio for pediatric plasmacytic PTLD.
A recently approved TIW schedule provides new option for patients with ALL or LBL receiving asparaginase.
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Robert E. Brown, MD, and collaborating researchers from the University of Texas Health Science Center at Houston McGovern ...
A study published in the Journal of Cancer Research and Clinical Oncology discussed outcomes of anti-CD20-based combination ...
Data on diffuse large B-cell lymphoma (DLBCL) from the OncoCollect Lymphoma group registry were recently published in ...
A study published in European Radiology examined the prognostic efficacy of automatic segmentation of diffuse large B-cell ...
According to a study published in the International Journal of Radiation Oncology, Biology, Physics, approximately 50% of ...
According to an article in Translational Cancer Research, data on the clinical outcomes of patients with primary diffuse ...
Recent first-line randomized controlled trials (RCTs) for patients with diffuse large B-cell lymphoma (DLCBL) have ...
Advertisement
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.
Advertisement
Advertisement
Latest News
Pamela K. Ginex, EdD, MPH, RN, OCN, outlines what oncology nurses need to know about adherence and best practices.
Nurse-Led Individualized Follow-ups After Early Breast Cancer Improve Quality of Life, Mental Health
The MyHealth study showed nurse-led visits significantly improved multiple outcomes over regular physician-led visits.
The AMBER study investigated sleep health, sleep quality, and physical and mental well-being in more than 1,400 patients.
